Weiss Amir (CIK 1897057) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Sell TEVA (10,679 shares), Buy TEVA (3,537 shares), Buy TEVA (10,679 shares), Buy TEVA (5,650 shares), Buy TEVA (5,179 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 10,679 | $384,444 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 3,537 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 10,679 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,650 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,179 | $0 |
| 2025-12-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 12,300 | $371,460 |
| 2025-11-10 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 12,300 | $300,612 |
| 2025-03-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 3,566 | $0 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 10,676 | $0 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,650 | $0 |
| 2025-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,179 | $0 |
Source: SEC Form 4 filings · as of 2026-05-07